SCHEMBL6843434

SCHEMBL6843434

COC1CC(C=C(C)C2OC(=O)C3CCCCN3C(=O)C(=O)C3(O)OC(C(OC)CC(C)C/C(C)=C/CC(=O)CC(O)C2C)C(OC)CC3C)CCC1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 18/20 0.78
FKBP4 Q02790 2/20 0.78
MEN1 O00255 1/20 0.78
LMNA P02545 1/20 0.78
MAPT P10636 1/20 0.78
KMT2A Q03164 1/20 0.78
THRB P10828 1/20 0.78
ABCB11 O95342 2/20 0.76
ADORA3 P0DMS8 2/20 0.76
MLNR O43193 1/20 0.76
NR1I2 O75469 1/20 0.76
CYP3A4 P08684 1/20 0.76
ADRA2A P08913 1/20 0.76
ADRB3 P13945 1/20 0.76
CYP3A5 P20815 1/20 0.76
TBXA2R P21731 1/20 0.76
CYP3A7 P24462 1/20 0.76
HTR2A P28223 1/20 0.76
HTR2B P41595 1/20 0.76
MTOR P42345 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15317850 1.00 FKBP1A (0.78) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL6843433 1.00 FKBP1A (0.78) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL6843435 1.00 FKBP1A (0.78) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL16907133 0.94 FKBP1A (0.70) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL6394830 0.94 FKBP1A (0.70) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL6849593 0.94 FKBP1A (0.70) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL20793518 0.90 FKBP1A (0.68) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL13900961 0.90 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL6942031 0.90 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT
SCHEMBL13817839 0.90 FKBP1A (0.86) FKBP1AFKBP4MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183261-B1 METHOD FOR SEPARATING ANALOGOUS ORGANIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO (JP) 2004-09-01 EP claimed
US-6492513-B1 METHOD FOR SEPARATING A LACTONE-CONTAINING HIGH-MOLECULAR WEIGHT COMPOUND HAVING AN ALKYL GROUP AS ITS SIDE CHAIN FROM A LACTONE-CONTAINING HIGH-MOLECULAR WEIGHT COMPOUND HAVING AN ALKENYL GROUP AS ITS SIDE CHAIN, SAID LACTONE-CONTAINING FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-10 US claimed
EP-1183261-A1 METHOD FOR SEPARATING ANALOGOUS ORGANIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-06 EP claimed
WO-2000071546-A1 METHOD FOR SEPARATING ANALOGOUS ORGANIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-30 WO claimed
EP-1183261-B1 METHOD FOR SEPARATING ANALOGOUS ORGANIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO (JP) 2004-09-01 EP disclosed
US-6492513-B1 METHOD FOR SEPARATING A LACTONE-CONTAINING HIGH-MOLECULAR WEIGHT COMPOUND HAVING AN ALKYL GROUP AS ITS SIDE CHAIN FROM A LACTONE-CONTAINING HIGH-MOLECULAR WEIGHT COMPOUND HAVING AN ALKENYL GROUP AS ITS SIDE CHAIN, SAID LACTONE-CONTAINING FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-10 US disclosed